(EYEN) $4.19--FDA Decision in October + another 2x attractive Phase 3 Drugs with near term readout ...could run to $10 and more ahead of the PDUFA date in october .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.